Medicine:Aquablation therapy
| Aquablation therapy | |
|---|---|
| Specialty | urology |
Aquablation therapy (AquaBeam) is a surgical procedure for men with lower urinary tract symptoms resulting from benign prostatic hyperplasia (BPH). It is in the early stages of study.[1] It is not categorized as minimally invasive as general anesthesia is required.[2] The procedure was developed by PROCEPT BioRobotics and combines real-time visualization through a cystoscope and a bi-plane ultrasound, while using a high-velocity sterile saline heat-free waterjet and autonomous robotics to remove prostate tissue.[3][4]
A systematic review from 2019 found that for men with lower urinary tract symptoms, aquablation is probably as effective as transurethral resection of the prostate in improving urinary symptoms and may lead to a similar quality of life.[5] The evidence from this review with a 12-month follow-up is very uncertain if aquablation leads to similar rates of serious side effects or a similar need for retreatment when compared to transurethral resection of the prostate. Aquablation may lead to fewer ejaculatory problems, but no difference in erectile function. These findings were based on a single study with 184 men with a prostate size less or equal to 80 mL funded by the company that manufactures the device.[citation needed]
References
- ↑ "Aquablation - Early Clinical Results". Current Bladder Dysfunction Reports 11 (2): 130–133. June 2016. doi:10.1007/s11884-016-0364-5.
- ↑ "Benign Prostatic Hyperplasia (BPH) Guideline - American Urological Association". https://www.auanet.org/guidelines/benign-prostatic-hyperplasia-(bph)-guideline.
- ↑ "Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience". BJU International 117 (6): 923–9. June 2016. doi:10.1111/bju.13358. PMID 26477826.
- ↑ "How I do it: Aquablation of the prostate using the AQUABEAM system". The Canadian Journal of Urology 23 (6): 8590–8593. December 2016. PMID 27995858. http://www.canjurol.com/html/free-articles/JUv23_I06_16_FREE_DrGilling.pdf.
- ↑ "Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia". The Cochrane Database of Systematic Reviews 2019 (2): CD013143. February 2019. doi:10.1002/14651858.CD013143.pub2. PMID 30759311.
 |  |
